Health Care & Life Sciences » Biotechnology | Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp.
Stock Exchange Other OTC
EPS
$0.09
Market Cap
$10.58 M
Shares Outstanding
406.45 M
Public Float
-
Abattis Bioceuticals Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
406.45 M
Public Float
-

Profile

Address
970 Burrard Street
Vancouver British Columbia V6Z 2R4
Canada
Employees -
Website http://www.abattis.com
Updated 07/08/2019
Abattis Bioceuticals Corp. is an agricultural technology and bio-technology company, which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. It operates through the following segments: Sciences, Products, and Technologies.

Financials

View All
Created with Highcharts 5.0.14Abattis Bioceuticals Corp.Net Income. Fiscal year is October-September. All values CAD Thousands.1 1021 1027 5697 5694 4724 4722 3392 3397 6347 6342013201420152016201702k4k6k8k10k
Created with Highcharts 5.0.14Abattis Bioceuticals Corp.Sales/Revenue. Fiscal year is October-September. All values CAD Thousands.17177791910000201320142015201620170255075100

Robert Abenante
President, Chief Executive Officer & Director
Wolfgang Richter
Director